Literature DB >> 24493418

Methods for the construction of retroviral vectors and the generation of high-titer producers.

I Rivière1, M Sadelain.   

Abstract

Retroviral vectors are powerful tools for gene transfer that are useful in the context of experimental as well as clinical applications. Defective recombinant retroviruses allow for efficient gene transfer into a broad range of mammalian cells derived from different species and different tissues. Safe gene transfer can be achieved using helper-free viral stocks, owing to the development of vectors and packaging cell lines that minimize the probability of hazardous recombination events. Retrovirus-mediated gene transfer leads to stable proviral integration in the target-cell genome, a key feature when the foreign genetic material must be faithfully transmitted to the progeny of the transduced parental cell, murine leukemia virus (MLV)-based vectors accommodate numerous modifications, thus providing a plastic tool that can be tailored for very diverse applications.

Entities:  

Year:  1997        PMID: 24493418     DOI: 10.1385/0-89603-484-4:59

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  11 in total

1.  A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase.

Authors:  J G Tjuvajev; A Joshi; J Callegari; L Lindsley; R Joshi; J Balatoni; R Finn; S M Larson; M Sadelain; R G Blasberg
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression.

Authors:  A Jacobs; M Dubrovin; J Hewett; M Sena-Esteves; C W Tan; M Slack; M Sadelain; X O Breakefield; J G Tjuvajev
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

3.  A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.

Authors:  Yury Likar; Juan Zurita; Konstantin Dobrenkov; Larissa Shenker; Shangde Cai; Anton Neschadim; Jeffrey A Medin; Michel Sadelain; Hedvig Hricak; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2010-09       Impact factor: 10.057

4.  Frequency of missense mutations in the coding region of a eukaryotic gene transferred by retroviral vectors.

Authors:  Maria De Angioletti; Ana Rovira; Michel Sadelain; Lucio Luzzatto; Rosario Notaro
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Retroviral-mediated gene transfer in primary murine and human T-lymphocytes.

Authors:  I Rivière; H F Gallardo; A B Hagani; M Sadelain
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

6.  A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.

Authors:  Yury Likar; Konstantin Dobrenkov; Malgorzata Olszewska; Elena Vider; Larissa Shenker; Shangde Cai; Nagavarakishore Pillarsetty; Hedvig Hricak; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057

7.  Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials.

Authors:  Tulin Budak-Alpdogan; Isabelle Rivière
Journal:  Methods Mol Biol       Date:  2009

8.  PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers.

Authors:  Yury Likar; Konstantin Dobrenkov; Malgorzata Olszewska; Larissa Shenker; Shangde Cai; Hedvig Hricak; Vladimir Ponomarev
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

9.  The impact of γ-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use.

Authors:  Jehad Zweiri; Stephen E Christmas
Journal:  Cancer Cell Int       Date:  2017-10-24       Impact factor: 5.722

10.  Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes.

Authors:  A Krause; H F Guo; J B Latouche; C Tan; N K Cheung; M Sadelain
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.